A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 17, 2009

Primary Completion Date

June 18, 2010

Study Completion Date

June 18, 2010

Conditions

Mental Disorders

Interventions

DRUG

Drug

Placebo

DRUG

Drug

4mg and 8mg Study drug

Trial Locations (1)

GSK Investigational Site, Cambridge